ConductScience.org, home
bacterial vaginosis
API referenceFor AI assistants

Disease · MONDO_0005316

Comparisons in its trials46

Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.

1 to 20 of 46

Download this page as JSON
ComparisonGroup 1, with the outcomeGroup 2, with the outcomeParticipantsTrialSource
Clindamycin Phosphate Vaginal Gel, 2% vs Placebo Vaginal Gel (Universal HEC Placebo Gel): deaths from any cause0 of 2030 of 103306NCT04370548Trial comparisons
Clindamycin Phosphate Vaginal Gel, 2% vs Placebo Vaginal Gel (Universal HEC Placebo Gel): serious adverse events0 of 2031 of 103306NCT04370548Trial comparisons
VivaGel vs HEC Placebo: Adverse Events Potentially Related to Treatment17 of 1269 of 123249NCT01577537Trial comparisons
VivaGel vs HEC Placebo: serious adverse events0 of 1260 of 123249NCT01577537Trial comparisons
VivaGel vs HEC Placebo: Adverse Events Potentially Related to Treatment20 of 12614 of 121247NCT01577238Trial comparisons
VivaGel vs HEC Placebo: serious adverse events1 of 1260 of 121247NCT01577238Trial comparisons
VivaGel vs HEC Placebo: Number of Women With Nugent Cure at the TOC Visit16 of 12013 of 117237NCT01577537Trial comparisons
VivaGel vs HEC Placebo: Number of Women With Nugent Cure at the EOT Visit16 of 1206 of 117237NCT01577537Trial comparisons
VivaGel vs HEC Placebo: Number of Women With Clinical Cure at the Test of Cure Visit (TOC)34 of 12033 of 117237NCT01577537Trial comparisons
VivaGel vs HEC Placebo: Number of Women With Clinical Cure at the End of Treatment Visit (EOT)68 of 12025 of 117237NCT01577537Trial comparisons
VivaGel vs HEC Placebo: Number of Women With Nugent Cure at the TOC Visit11 of 1175 of 115232NCT01577238Trial comparisons
VivaGel vs HEC Placebo: Number of Women With Nugent Cure at the EOT Visit15 of 1173 of 115232NCT01577238Trial comparisons
VivaGel vs HEC Placebo: Number of Women With Clinical Cure at the Test of Cure Visit (TOC)31 of 11724 of 115232NCT01577238Trial comparisons
VivaGel vs HEC Placebo: Number of Women With Clinical Cure at the End of Treatment Visit (EOT)59 of 11719 of 115232NCT01577238Trial comparisons
Metronidazole vs Placebo: Number of Female Partners Whose Male Partners Received Metronidazole Versus Females Whose Male Partners Did Not Receive Metrodiazole With Recurrence of BV in the Female87 of 10786 of 107214NCT02209519Trial comparisons
Metronidazole vs Placebo: deaths from any cause0 of 1070 of 107214NCT02209519Trial comparisons
Metronidazole vs Placebo: serious adverse events0 of 1071 of 107214NCT02209519Trial comparisons
SYM-1219 vs Placebo: deaths from any cause0 of 1250 of 64189NCT02418845Trial comparisons
SYM-1219 vs Placebo: serious adverse events2 of 1250 of 64189NCT02418845Trial comparisons
Clindamycin Phosphate Vaginal Gel, 2% vs Placebo Vaginal Gel (Universal HEC Placebo Gel): Number of Patients With Bacteriological Cure at Interim Assessment Visit, Day 7-1450 of 1222 of 59181NCT04370548Trial comparisons

diseases-2026-09-18-0.1.0

Next page

Sources 6

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • NLM's MeSHNLM's terms
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • NLM's MeSHNLM's
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/diseases/v1/MONDO_0005316/comparisons

API referenceFor AI assistants